Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist

Clinics

Volumn 67, Issue 6, 2012, Pages 591-596

  Alessandri, Sandra B ^a   Pereira, Francisco de A ^a   Villela, Rosângela A ^a   Antonini, Sonir R R ^a   Elias, Paula C L ^a   Martinelli, Carlos E ^a   de Castro, Margaret ^a   Moreira, Ayrton C ^a   de Paula, Francisco J A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone density; Gonadotropin releasing hormone; Osteoporosis in children; Precocious puberty

Indexed keywords

EID: 84866340088     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(06)08     Document Type: Article

References (35)

1. Clarke BL, Khosla S. Female reproductive system and bone. Arch Biochem Biophys. 2010;503(1):118-28, http://dx.doi.org/10.1016/j.abb.2010.07.006.
2. Norris SA, Nelson DA. Ethnic differences in bone acquisition. In: Rosen CJ, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7th ed. Washington: Wiley, JW. 2008.p.80-2.
3. Saggese G, Bertelloni S, Baroncelli GI. Sex steroids and the acquisition of bone mass. Horm Res. 1997;48(Suppl 5):65-71, http://dx.doi.org/10.1159/000191331.
4. Grimston SK, Morrison K, Harder JA, Hanley DA. Bone mineral density during puberty in western Canadian children. Bone Miner. 1992;19(1):85-96, http://dx.doi.org/10.1016/0169-6009(92)90846-6.
5. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest. 1994;93(2):799-808, http://dx.doi.org/10.1172/JCI117034.
6. Holmes SJ, Shalet SM. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 1996;45(1-2):86-93.
7. Krabbe S, Transbol I, Christiansen C. Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept. Arch Dis Child. 1982;57(5):359-63, http://dx.doi.org/10.1136/adc.57.5.359.
8. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol. 1999;13(6):819-28, http://dx.doi.org/10.1210/me.13.6.819.
9. Vanderschueren D. Androgens and their role in skeletal homeostasis. Horm Res. 1996;46(2):95-8, http://dx.doi.org/10.1159/000185003.
10. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res. 1998;49(Suppl 1):2-8, http://dx.doi.org/10.1159/000053061.
11. Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr. 1993;152(9):717-20, http://dx.doi.org/10.1007/BF01953983.
12. Takahashi Y, Minamitani K, Kobayashi Y, Minagawa M, Yasuda T, Niimi H. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab. 1996;81(3):1248-53, http://dx.doi.org/10.1210/jc.81.3.1248.
13. Chevalley T, Bonjour JP, Ferrari S, Rizzoli R. Influence of age at menarche on forearm bone microstructure in healthy young women. J Clin Endocrinol Metab. 2008;93(7):2594-601, http://dx.doi.org/10.1210/jc.2007-2644.
14. Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab. 1996;81(3):1152-5, http://dx.doi.org/10.1210/jc.81.3.1152.
15. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992;326(9):600-4, http://dx.doi.org/10.1056/NEJM199202273260904.
16. Burrows M, Baxter-Jones A, Mirwald R, Macdonald H, McKay H. Bone mineral accrual across growth in a mixed-ethnic group of children: are Asian children disadvantaged from an early age? Calcif Tissue Int. 2009;84(5):366-78, http://dx.doi.org/10.1007/s00223-009-9236-8.
17. Golden NH. Osteoporosis prevention: a pediatric challenge. Arch Pediatr Adolesc Med. 2000;154(6):542-3.
18. Antoniazzi F, Bertoldo F, Lauriola S, Sirpresi S, Gasperi E, Zamboni G, et al. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab. 1999;84(6):1992-6, http://dx.doi.org/10.1210/jc.84.6.1992.
19. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab. 1999;84(12):4583-90, http://dx.doi.org/10.1210/jc.84.12.4583.
20. van der Sluis IM, Boot AM, Krenning EP, Drop SL, de Muinck Keizer-Schrama SM. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab. 2002;87(2):506-12, http://dx.doi.org/10.1210/jc.87.2.506.
21. Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab. 1999;84(10):3539-44, http://dx.doi.org/10.1210/jc.84.10.3539.
22. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7(2):137-45.
23. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, et al. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 2008;43(6):1115-21, http://dx.doi.org/10.1016/j.bone.2008.08.106.
24. de Albuquerque Taveira AT, Fernandes MI, Galvao LC, Sawamura R, de Mello Vieira E, de Paula FJ. Impairment of bone mass development in children with chronic cholestatic liver disease. Clin Endocrinol (Oxf). 2007;66(4):518-23.
25. Albright F, Bloomberg E, Smith P. Postmenopausal osteoporosis. Transactions of the Association of American Physicians. 1940;55:298-305.
26. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80(12):3689-98, http://dx.doi.org/10.1210/jc.80.12.3689.
27. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(2):1056-61, http://dx.doi.org/10.1056/NEJM199410203311604.
28. Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, et al. Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment. Eur J Endocrinol. 1995;133(4):412-7, http://dx.doi.org/10.1530/eje.0.1330412.
29. Ko JH, Lee HS, Lim JS, Kim SM, Hwang JS. Changes in bone mineral density and body composition in children with central precocious puberty and early puberty before and after one year of treatment with GnRH agonist. Horm Res Paediatr 2011;75(3):174-9.
30. Khosla S, Melton LJ3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 2011;26(3):441-51.
31. Riggs BL, Melton Iii LJ, 3rd, Robb RA, Camp JJ, Atkinson EJ, Peterson JM, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004;19(12):1945-54, http://dx.doi.org/10.1359/jbmr.040916.
32. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142(2):309-19, http://dx.doi.org/10.1016/j.cell.2010.06.002.
33. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010;11(1):11-22, http://dx.doi.org/10.1016/j.cmet.2009.11.007.
34. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008;105(13):5266-70, http://dx.doi.org/10.1073/pnas.0711119105.
35. Mantzoros CS, Moschos SJ. Leptin: in search of role(s) in human physiology and pathophysiology. Clin Endocrinol (Oxf). 1998;49(5):551-67, http://dx.doi.org/10.1046/j.1365-2265.1998.00571.x.